Houghton Mifflin Harcourt - HMHC Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Houghton Mifflin Harcourt in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HMHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HMHC, but not buy additional shares or sell existing shares.
View HMHC analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 12-month price targets for Houghton Mifflin Harcourt's shares. Their HMHC share price forecasts range from $19.00 to $21.00. On average, they anticipate the company's stock price to reach $20.00 in the next year. This suggests that the stock has a possible downside of 4.9%.
View analysts price targets for HMHC or view top-rated stocks among Wall Street analysts.

Houghton Mifflin Harcourt (NASDAQ:HMHC) announced its quarterly earnings results on Thursday, November, 4th. The business services provider reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.54. The business services provider earned $417.10 million during the quarter, compared to analysts' expectations of $345.29 million. Houghton Mifflin Harcourt had a trailing twelve-month return on equity of 0.81% and a net margin of 20.33%. The business's revenue for the quarter was up 25.9% compared to the same quarter last year.

195 employees have rated Houghton Mifflin Harcourt Chief Executive Officer John “Jack” J. Lynch, Jr. on Glassdoor.com. John “Jack” J. Lynch, Jr. has an approval rating of 67% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Houghton Mifflin Harcourt investors own include Energy Transfer (ET), Ford Motor (F), Pearson (PSO), Advanced Micro Devices (AMD), General Electric (GE), International Business Machines (IBM), Heat Biologics (HTBX), Lumen Technologies (LUMN), Oasis Petroleum (OAS) and Pfizer (PFE).

Houghton Mifflin Harcourt trades on the NASDAQ under the ticker symbol "HMHC."

One share of HMHC stock can currently be purchased for approximately $21.03.

Houghton Mifflin Harcourt (NASDAQ:HMHC) has a market capitalization of $2.69 billion and generates $1.05 billion in revenue each year. The business services provider earns $213.58 million in net income (profit) each year or $1.61 on an earnings per share basis.

The company employs 2,300 workers across the globe.

Houghton Mifflin Harcourt's mailing address is 125 HIGH STREET, BOSTON MA, 02110. The official website for the company is www.hmhco.com. The business services provider can be reached via phone at (617) 351-5000 or via email at brian.shipman@hmhco.com.